Robert N. Shapiro’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$6.4M Sell
108,475
-8,712
-7% -$491K 1.28% 16
2014
Q3
$6M Sell
117,187
-14,634
-11% -$731K 1.14% 18
2014
Q2
$6.39M Buy
131,821
+3,511
+3% +$173K 1.21% 16
2014
Q1
$6.66M Sell
128,310
-5,042
-4% -$268K 1.23% 15
2013
Q4
$7.09M Sell
133,352
-10,046
-7% -$512K 1.27% 14
2013
Q3
$6.64M Buy
143,398
+46,047
+47% +$2.02M 1.17% 16
2013
Q2
$4.35M Buy
+97,351
New +$4.23M 0.91% 25

Other funds holding BMY

Robert N. Shapiro's BMY Position: Q4 2014 in Review

Robert N. Shapiro reduced its Bristol-Myers Squibb (BMY) stake by 7.4% in Q4 2014, selling an estimated $491K and leaving 108,475 shares worth $6.4M. The position accounts for 1.28% of the portfolio, ranked #16.

Robert N. Shapiro first reported a position in BMY in Q2 2013 and has held it in 7 quarters since. The position peaked at $7.09M in Q4 2013. 1,409 funds tracked by Wall St. Rank hold BMY as of Q4 2014.

  • Robert N. Shapiro held 108,475 shares of Bristol-Myers Squibb worth $6.4M as of Q4 2014.
  • Robert N. Shapiro sold 8,712 Bristol-Myers Squibb shares in Q4 2014, an estimated $491K.
  • Bristol-Myers Squibb made up 1.28% of Robert N. Shapiro's portfolio in Q4 2014, its #16 holding.
  • Robert N. Shapiro first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 7 quarters since.
  • Robert N. Shapiro's Bristol-Myers Squibb position peaked at $7.09M in Q4 2013.
  • 1,409 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.